ING Groep NV Trims Stock Position in Axon Enterprise, Inc. (NASDAQ:AXON)

ING Groep NV lessened its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 82.2% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,502 shares of the biotechnology company's stock after selling 11,544 shares during the quarter. ING Groep NV's holdings in Axon Enterprise were worth $1,000,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of AXON. PFG Investments LLC boosted its position in Axon Enterprise by 0.6% in the third quarter. PFG Investments LLC now owns 3,872 shares of the biotechnology company's stock valued at $1,547,000 after buying an additional 25 shares during the last quarter. Gladstone Institutional Advisory LLC lifted its stake in Axon Enterprise by 1.6% during the 3rd quarter. Gladstone Institutional Advisory LLC now owns 1,641 shares of the biotechnology company's stock valued at $656,000 after acquiring an additional 26 shares during the period. Mather Group LLC. lifted its stake in Axon Enterprise by 3.7% during the 3rd quarter. Mather Group LLC. now owns 759 shares of the biotechnology company's stock valued at $303,000 after acquiring an additional 27 shares during the period. CWM LLC boosted its holdings in shares of Axon Enterprise by 1.3% in the 3rd quarter. CWM LLC now owns 2,856 shares of the biotechnology company's stock valued at $1,141,000 after acquiring an additional 36 shares during the last quarter. Finally, SPC Financial Inc. increased its stake in shares of Axon Enterprise by 2.2% in the third quarter. SPC Financial Inc. now owns 1,773 shares of the biotechnology company's stock worth $708,000 after acquiring an additional 38 shares during the period. 79.08% of the stock is owned by institutional investors and hedge funds.

Axon Enterprise Stock Down 0.9 %

Shares of AXON opened at $599.35 on Monday. The stock has a 50 day moving average price of $438.79 and a 200 day moving average price of $357.90. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The stock has a market capitalization of $45.70 billion, a price-to-earnings ratio of 154.87, a PEG ratio of 15.05 and a beta of 0.94. Axon Enterprise, Inc. has a one year low of $220.78 and a one year high of $624.84.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 21,834 shares of the stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total value of $12,966,775.92. Following the completion of the sale, the insider now owns 154,394 shares in the company, valued at approximately $91,691,508.72. This represents a 12.39 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Patrick W. Smith sold 80,300 shares of the company's stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $371.78, for a total value of $29,853,934.00. Following the completion of the sale, the chief executive officer now owns 3,015,366 shares of the company's stock, valued at $1,121,052,771.48. This trade represents a 2.59 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 411,006 shares of company stock valued at $161,360,618 over the last 90 days. 6.10% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

AXON has been the topic of several recent research reports. JMP Securities upped their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a "market outperform" rating in a report on Thursday, October 31st. Robert W. Baird upped their target price on Axon Enterprise from $440.00 to $460.00 and gave the stock an "outperform" rating in a research note on Monday, November 4th. Craig Hallum lifted their price target on Axon Enterprise from $370.00 to $376.00 and gave the company a "buy" rating in a research report on Wednesday, August 7th. Northland Securities upped their price objective on Axon Enterprise from $365.00 to $550.00 and gave the stock an "outperform" rating in a research report on Monday, November 11th. Finally, Barclays lifted their target price on shares of Axon Enterprise from $381.00 to $387.00 and gave the company an "overweight" rating in a report on Wednesday, August 7th. Two analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $427.83.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.